Eisai makes Shaji Procida VP and CFO
This article was originally published in Scrip
Executive Summary
Eisai Inc, the US subsidiary of Eisai Co, has promoted Shaji Procida from vice-president of finance to vice-president and chief financial officer. Ms Procida has worked at Eisai since 1998 in roles of increasing responsibility.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.